Nivolumab and Relatlimab

About

Membership operator: AND

Therapies: 2

Therapies

Nivolumab (tx:ncit:C68814)

Relatlimab (tx:ncit:C111999)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy group.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
EMA (1) PD-L1 < 1% Melanoma Nivolumab, Relatlimab